Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001573626 | SCV002228550 | uncertain significance | not provided | 2022-06-05 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1206240). This variant has not been reported in the literature in individuals affected with LAMA1-related conditions. This variant is present in population databases (rs760542877, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 2772 of the LAMA1 protein (p.Arg2772Cys). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002568475 | SCV003677671 | uncertain significance | Inborn genetic diseases | 2024-08-21 | criteria provided, single submitter | clinical testing | The c.8314C>T (p.R2772C) alteration is located in exon 58 (coding exon 58) of the LAMA1 gene. This alteration results from a C to T substitution at nucleotide position 8314, causing the arginine (R) at amino acid position 2772 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Laboratory of Diagnostic Genome Analysis, |
RCV001573626 | SCV001799787 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573626 | SCV001975384 | likely benign | not provided | no assertion criteria provided | clinical testing |